ProSomnus Announces Strong First Quarter 2024 Revenue Growth
16 mai 2024 08h42 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Announces Strong First Quarter 2024 Revenue Growth
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
13 mai 2024 09h00 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Contributes Two Scientific Abstracts Accepted for Presentation at the 2024 American Academy of Dental Sleep Medicine Annual Meeting
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
09 mai 2024 18h30 HE
|
ProSomnus Sleep Technologies, Inc.
Four Independent Scientific Abstracts at the American Academy of Dental Sleep Medicine Annual Meeting Feature ProSomnus Intraoral Medical Devices
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
08 mai 2024 20h53 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Sleep Technologies Takes Strategic Action to Position Company for Long-Term Success
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
26 mars 2024 16h05 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
15 mars 2024 20h01 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
22 févr. 2024 08h30 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024
20 févr. 2024 16h05 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call & Participation at the 36th Annual ROTH Conference in March 2024
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
30 janv. 2024 08h00 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices
29 janv. 2024 08h00 HE
|
ProSomnus Sleep Technologies, Inc.
ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices